ImageneBio (IMA) Change in Cash (2020 - 2025)
ImageneBio (IMA) posted Change in Cash of $72.1 million for Q3 2025, up 176.46% sequentially from $26.1 million in Q2 2025, and up 4.68% YoY from $68.9 million in Q3 2024.
ImageneBio (IMA) Change in Cash (2020 - 2025) Analysis & Trends
ImageneBio has reported Change in Cash for 6 years, with the latest figure at $72.1 million in Q3 2025.
- Quarterly Change in Cash rose 4.68% year-over-year to $72.1 million in Q3 2025, while the trailing twelve-month figure through Sep 2025 was $16.8 million (up 308.21% YoY) and the FY2024 annual result came in at -$80.9 million, down 233.99% from the prior year.
- Change in Cash advanced to $72.1 million in Q3 2025 per IMA's latest filing, from $26.1 million in the prior quarter.
- Over five years, Change in Cash peaked at $118.5 million in Q1 2021 and troughed at -$185.3 million in Q1 2022.
- A 5-year average of -$1.7 million and a median of -$7.2 million in 2022 frame the typical range for Change in Cash.
- The sharpest annual moves came in 2023 and 2024: Change in Cash soared 2480.06% in 2023, then tumbled 5265.15% in 2024.
- Over 5 years, Change in Cash stood at -$13.7 million in 2021, then soared by 47.71% to -$7.2 million in 2022, then soared by 80.67% to -$1.4 million in 2023, then sank by 5265.15% to -$74.2 million in 2024, then jumped by 197.23% to $72.1 million in 2025.
- According to Business Quant data, Change in Cash over the past three periods registered $72.1 million, $26.1 million, and -$7.2 million for Q3 2025, Q2 2025, and Q1 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Cash (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 649.20 Mn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | -504.60 Mn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | -185.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 427.25 Mn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | -2.94 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | -2.83 Bn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | -37.42 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 225.59 Mn |
| 10 | ImageneBio | 47.79 Mn | -87.56 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 72.15 Mn |
| Jun 30, 2025 | 26.10 Mn |
| Mar 31, 2025 | -7.20 Mn |
| Dec 31, 2024 | -74.20 Mn |
| Sep 30, 2024 | 68.92 Mn |
| Jun 30, 2024 | -8.58 Mn |
| Mar 31, 2024 | -67.04 Mn |
| Dec 31, 2023 | -1.38 Mn |
| Sep 30, 2023 | 50.82 Mn |
| Jun 30, 2023 | 41.54 Mn |
| Mar 31, 2023 | -30.59 Mn |
| Dec 31, 2022 | -7.16 Mn |
| Sep 30, 2022 | 18.59 Mn |
| Jun 30, 2022 | 1.61 Mn |
| Mar 31, 2022 | -185.34 Mn |
| Dec 31, 2021 | -13.68 Mn |
| Sep 30, 2021 | -18.11 Mn |
| Jun 30, 2021 | -17.01 Mn |
| Mar 31, 2021 | 118.52 Mn |
| Dec 31, 2020 | 106.63 Mn |